Price
No data yet.
Social Signal Score
Analyst Ratings
17 analystsRevenue
$373.54M+40.29%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Marc Whitten
- Sector
- Technology
- Industry
- Software - Application
- Employees
- 2,000
- Beta
- 0.78
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 7.89
Financials
Revenue
$373.54M+40.3%Net Income
$80.89M+51.6%EBITDA
$126.44M+41.3%Free Cash Flow
$55.23M+14.7%EPS (diluted)
$0.86+68.6%Shares Outstanding (diluted)
93.98M-9.5%Operating Expenses
$221.33MCash & Debt
$623.38MReturn of Capital
$100.17MRevenue by Segment (annual)
$1.42BDividend per Share
$0.39Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $1.42B | $257.74M | $2.73 |
| 2025 | $1.35B | $255.02M | $2.66 |
| 2024 | $1.27B | $261.82M | $2.74 |
| 2023 | $1.30B | $200.66M | $2.00 |
| 2022 | $1.25B | $184.09M | $1.84 |
| 2021 | $1.28B | $310.23M | $3.07 |
| 2020 | $1.16B | $231.36M | $2.30 |
| 2019 | $1.24B | $255.15M | $2.51 |
| 2018 | $1.05B | $41.75M | $1.18 |
| 2017 | $1.08B | $201.80M | $1.98 |
| 2016 | $1.03B | $185.86M | $1.85 |
| 2015 | $970.64M | $181.39M | $1.75 |
| 2014 | $960.18M | $206.10M | $2.02 |
| 2013 | $909.67M | $189.27M | $1.86 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from DLB's reported EPS growth of 3.0% a year over 13 years.
- EPS in 5 years
- $3.16
- Implied price
- $66.35
- Return from $55.33
- 3.7% a year
To earn 15.0% a year on these assumptions you'd need to buy at $32.99 — -40.4% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 15 | 18 | 21 | 24 | 27 |
|---|---|---|---|---|---|
| -7.0% | -12.5% | -9.2% | -6.4% | -3.8% | -1.5% |
| -2.0% | -7.8% | -4.3% | -1.3% | 1.3% | 3.8% |
| 3.0% | -3.0% | 0.6% | 3.7% | 6.5% | 9.0% |
| 8.0% | 1.7% | 5.4% | 8.7% | 11.7% | 14.3% |
| 13.0% | 6.4% | 10.3% | 13.8% | 16.8% | 19.6% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
156+159.67%Social Signal Score
Mentions (26)
- News (RSS)zerohedge·4d ago·Neutral
…ty distribution agreement.Bullish (BLSH) gains 8% after the crypto exchange reported third-quarter adjusted Ebitda that beat the average analyst estimate.Dolby Labs (DLB) falls 3% after the developer of audio and voice technologies gave a 2027 forecast for adjusted earnings per share that missed the consensus estimate.Lowe’s (LOW) slips 3% after the home improvement retailer’s third quarter adj. EPS topped expectations by 18c, but management maintained its annual guidance. All together, the impl…
View source ↗ - Newsfool.com·4d ago·Positive
Dolby: 3 Key Takeaways for Long-Term Investors Advanced audio and imaging patents generated over 50% of licensing revenue. The Video Distribution Patent Program expanded to 47 licensors.
View source ↗ - Newszacks.com·4d ago·Positive
Why Dolby Laboratories (DLB) is a Top Growth Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
View source ↗ - News (RSS)seekingalpha·4d ago·Neutral
Dolby Laboratories boost dividend by 8.3% to $0.39 a share
View source ↗ - News (RSS)seekingalpha·4d ago·Neutral
Dolby Laboratories boost dividend by 8.3% to $0.39 a share
View source ↗ - News (Marketaux)seekingalpha.com·4d ago·Positive
Dolby forecasts FY 2027 revenue of about $1.42B amid flattish operating margins Earnings Call Insights Dolby forecasts F[+140 characters]
View source ↗ - News (Marketaux)seekingalpha.com·4d ago·Positive
Dolby Laboratories, Inc. (DLB) Q4 2026 Earnings Call Transcript Welcome to the Dolby Labora[+340 characters]
View source ↗ - News (RSS)seekingalpha·4d ago·Neutral
Dolby Laboratories, Inc. 2026 Q4 - Results - Earnings Call Presentation
View source ↗ - News (RSS)investing·4d ago·Neutral
Dolby Q4 2026 slides: new CEO, revenue mix shift, flat outlook
View source ↗ - News (RSS)investing·24d ago·Neutral
CervoMed publishes phase 2b trial results for DLB treatment
View source ↗ - Newsglobenewswire.com·24d ago·Neutral
CervoMed Announces Publication of Two Peer-Reviewed Research Articles Supporting Neflamapimod as a Potential Treatment for Dementia with Lewy Bodies (DLB) Placebo-controlled results of RewinD-LB clinical trial published in Alzheimer's Research & Therapy provides further evidence of the potential of neflamapimod to slow clinical disease progression in DLB
View source ↗ - Newsprnewswire.com·41d ago·Neutral
… Laboratories Announces Conference Call and Webcast for Q4 Fiscal 2026 Financial Results SAN FRANCISCO, Oct. 12, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment, will release financial results for the fourth quarter (Q4) and full year fiscal 2026 after the close of regular trading on Tuesday, November 17, 2026. Members of Dolby management will lead a conference call open to all interested parties to discuss Q4 fiscal year 2026 financial results for …
View source ↗ - News (RSS)seekingalpha·48d ago·Negative
Dolby Laboratories: Weak Growth, But The Valuation Is Too Cheap
View source ↗ - Newsseekingalpha.com·48d ago·Positive
Dolby Laboratories: Weak Growth, But The Valuation Is Too Cheap Dolby Laboratories is rated Buy due to its high margins, robust buyback program, and undervalued share price despite weak growth. DLB's 90% gross margin and operating leverage enable EPS growth even with modest revenue increases and stagnant licensing. Share repurchases—authorized up to $427 million—could alone drive EPS to levels supporting a 15x multiple and 20%+ upside.
View source ↗ - Newsglobenewswire.com·54d ago·Neutral
Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial of Zervimesine (CT1812) in DLB October 20th Meeting with the Division of Neurology Expected to Define Endpoint for Phase 3 October 20th Meeting with the Division of Neurology Expected to Define Endpoint for Phase 3
View source ↗ - Newszacks.com·59d ago·Neutral
Dolby Expands Meta Partnership With Atmos and Vision Across Devices DLB expands across Meta's ecosystem as Dolby Atmos and Vision reach AI glasses, Instagram and VR, broadening its digital content footprint.
View source ↗ - Newsprnewswire.com·60d ago·Neutral
Dolby and Meta Expand Dolby Atmos and Dolby Vision Across Meta's Ecosystem /PRNewswire/ -- Today, Dolby Laboratories (NYSE: DLB) and Meta (NASDAQ: META) announced the expansion of Dolby experiences within the Meta ecosystem of devices
View source ↗ - Newsprnewswire.com·68d ago·Neutral
Dolby Laboratories, Inc. Grants Inducement Equity Awards Under Its 2026 Inducement Stock Plan SAN FRANCISCO, Sept. 15, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB) ("Dolby"), a leader in immersive entertainment, today announced it has granted inducement awards under its 2026 Inducement Stock Plan (the "Plan") to its new President and Chief Executive Officer, Marc Whitten, as inducement awards in connection with the commencement of his employment.
View source ↗ - News (RSS)economictimes·74d ago·Positive
iPhone 18 Pro @ $1,199 packs in more AI Apple has introduced the iPhone 18 Pro and iPhone 18 Pro Max, bringing major upgrades across performance, on-device AI, cameras, battery life and thermal management. At the heart of the new Pro models is the A20 Pro chip, which delivers significant gains in CPU, GPU and neural processing while enabling more powerful on-device Apple Intelligence features. The iPhone 18 Pro starts at $1,199, while the iPhone 18 Pro Max starts at $1,299 in the US.The iPhone 1
View source ↗ - Newsprnewswire.com·76d ago·Neutral
RayNeo präsentiert auf der IFA 2026 gemeinsam mit Dolby und Bang & Olufsen eine neue Generation von Smart-Brillen mit KI-Funktionen und kinoreifem AR-Erlebnis /PRNewswire/ -- RayNeo, ein weltweit führender Anbieter von Augmented-Reality-Brillen (AR) für Endverbraucher, präsentierte auf der IFA 2026 sein neuestes
View source ↗ - Newsprnewswire.com·76d ago·Neutral
RayNeo présente ses lunettes IA à réalité augmentée cinématographique à l'IFA 2026 en collaboration avec Dolby et Bang & Olufsen /PRNewswire/ -- RayNeo, leader mondial des lunettes de réalité augmentée (RA) grand public, a présenté sa toute dernière gamme de produits de calcul spatial
View source ↗ - Newszacks.com·82d ago·Positive
Dolby Laboratories (DLB) is a Top-Ranked Growth Stock: Should You Buy? Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
View source ↗ - Newszacks.com·83d ago·Neutral
3 Audio Video Stocks to Watch as the Industry Grapples With Headwinds Amid cautious discretionary spending and macro troubles, investments in cutting-edge solutions are likely to aid Zacks Audio Video Production industry participants like SONY, DLB and SONO.
View source ↗ - Newszacks.com·83d ago·Positive
Dolby Laboratories (DLB) is a Top-Ranked Momentum Stock: Should You Buy? Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
View source ↗ - Newsprnewswire.com·87d ago·Positive
… from Dolby Marc Whitten Named President, Chief Executive Officer and Director of Dolby SAN FRANCISCO, Aug. 27, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), today announced a new chapter in its leadership as Kevin Yeaman retires from Dolby after nearly two decades with the company and Marc Whitten is appointed President, Chief Executive Officer and a member of Dolby Laboratories' Board of Directors. After a thoughtful, long-term succession process Dolby Laboratories' Board appoint…
View source ↗ - Newszacks.com·102d ago·Positive
Here's Why Dolby Laboratories (DLB) is a Strong Growth Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
View source ↗
Earnings
Thu, Feb 4(in 2 months)
Consensus estimate $0.50 per share
Typical surprise +4.6% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Nov 17$1.25 vs $1.20beat
- Thu, Jul 30$0.69 vs $0.67beat
- Thu, Apr 30$1.37 vs $1.31beat
- Thu, Jan 29$1.06 vs $0.99beat
- Tue, Nov 18$0.99 vs $0.70beat
- Thu, Jul 31$0.78 vs $0.72beat
Estimates and results for DLB via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by DLB officers and directors.
- Bought
- —
- Sold
- $7.1m
0 trades
25 trades
- Couling John Dsold
- Couling John Dsold
- Couling John Dsold
- Nicholson Ryansold
- Revankar Shriramsold
- Nicholson Ryansold
- Nicholson Ryansold
- Couling John Dsold
75 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Lisa C. McClainhouse · MI09 · disclosed Oct 22, 2025 (41d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Oct 22, 2025 (27d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Sep 15, 2025 (42d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (50d later)Buy$1,001 - $15,000
- Donna Shalalahouse · FL27 · disclosed Apr 27, 2020 (308d later)Sell$1,001 - $15,000
- Lamar Seeligson Smithhouse · TX21 · disclosed Oct 9, 2018 (13d later)Buy$1,001 - $15,000
- Lamar Seeligson Smithhouse · TX21 · disclosed Sep 7, 2018 (30d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
